| Target and Pathway |
Top |
| Target(s) |
Cyclin-dependent kinase 1 (CDK1) |
Target Info
|
Inhibitor |
[1] |
| Cyclin-dependent kinase 2 (CDK2) |
Target Info
|
Inhibitor |
[1] |
| Cyclin-dependent kinase 5 (CDK5) |
Target Info
|
Inhibitor |
[1] |
| Cyclin-dependent kinase 9 (CDK9) |
Target Info
|
Inhibitor |
[1] |
| Target's Patent Info |
Cyclin-dependent kinase 1 (CDK1) |
Target's Patent Info
|
[1] |
| Cyclin-dependent kinase 2 (CDK2) |
Target's Patent Info
|
[1] |
| Cyclin-dependent kinase 5 (CDK5) |
Target's Patent Info
|
[1] |
| Cyclin-dependent kinase 9 (CDK9) |
Target's Patent Info
|
[1] |
|
KEGG Pathway
|
Transcriptional misregulation in cancer
|
|
Cell cycle
|
|
Oocyte meiosis
|
|
p53 signaling pathway
|
|
Gap junction
|
|
Progesterone-mediated oocyte maturation
|
|
Herpes simplex infection
|
|
Epstein-Barr virus infection
|
|
Viral carcinogenesis
|
|
Axon guidance
|
|
Alzheimer's disease
|
|
Cocaine addiction
|
|
FoxO signaling pathway
|
|
PI3K-Akt signaling pathway
|
|
Hepatitis B
|
|
Measles
|
|
Pathways in cancer
|
|
Prostate cancer
|
|
Small cell lung cancer
|
|
NetPath Pathway
|
EGFR1 Signaling Pathway
|
|
RANKL Signaling Pathway
|
|
TCR Signaling Pathway
|
|
Panther Pathway
|
Axon guidance mediated by semaphorins
|
|
p53 pathway
|
|
p53 pathway feedback loops 2
|
|
Pathway Interaction Database
|
p73 transcription factor network
|
|
E2F transcription factor network
|
|
PLK1 signaling events
|
|
AP-1 transcription factor network
|
|
FOXM1 transcription factor network
|
|
Retinoic acid receptors-mediated signaling
|
|
Reelin signaling pathway
|
|
Glucocorticoid receptor regulatory network
|
|
Lissencephaly gene (LIS1) in neuronal migration and development
|
|
EPHA forward signaling
|
|
Trk receptor signaling mediated by the MAPK pathway
|
|
Regulation of nuclear SMAD2/3 signaling
|
|
Signaling events mediated by PRL
|
|
ATR signaling pathway
|
|
mTOR signaling pathway
|
|
IL2-mediated signaling events
|
|
FoxO family signaling
|
|
BARD1 signaling events
|
|
p53 pathway
|
|
Regulation of retinoblastoma protein
|
|
Reactome
|
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
|
|
MAPK3 (ERK1) activation
|
|
E2F mediated regulation of DNA replication
|
|
G0 and Early G1
|
|
Cyclin B2 mediated events
|
|
Golgi Cisternae Pericentriolar Stack Reorganization
|
|
Cdc20:Phospho-APC/C mediated degradation of Cyclin A
|
|
Regulation of APC/C activators between G1/S and early anaphase
|
|
Phosphorylation of the APC/C
|
|
Phosphorylation of Emi1
|
|
Condensation of Prophase Chromosomes
|
|
MASTL Facilitates Mitotic Progression
|
|
Resolution of Sister Chromatid Cohesion
|
|
Condensation of Prometaphase Chromosomes
|
|
Regulation of PLK1 Activity at G2/M Transition
|
|
Activation of NIMA Kinases NEK9, NEK6, NEK7
|
|
Loss of Nlp from mitotic centrosomes
|
|
Recruitment of mitotic centrosome proteins and complexes
|
|
Loss of proteins required for interphase microtubule organization?from the centrosome
|
|
Recruitment of NuMA to mitotic centrosomes
|
|
Depolymerisation of the Nuclear Lamina
|
|
Anchoring of the basal body to the plasma membrane
|
|
MAPK6/MAPK4 signaling
|
|
G1/S-Specific Transcription
|
|
Cyclin A/B1 associated events during G2/M transition
|
|
G2/M DNA replication checkpoint
|
|
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
|
|
DARPP-32 events
|
|
CRMPs in Sema3A signaling
|
|
Factors involved in megakaryocyte development and platelet production
|
|
Activation of ATR in response to replication stress
|
|
SCF(Skp2)-mediated degradation of p27/p21
|
|
Senescence-Associated Secretory Phenotype (SASP)
|
|
DNA Damage/Telomere Stress Induced Senescence
|
|
Processing of DNA double-strand break ends
|
|
G2 Phase
|
|
Orc1 removal from chromatin
|
|
Cyclin E associated events during G1/S transition
|
|
p53-Dependent G1 DNA Damage Response
|
|
Cyclin A:Cdk2-associated events at S phase entry
|
|
Meiotic recombination
|
|
WikiPathways
|
Cardiac Hypertrophic Response
|
|
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
|
|
Host Interactions of HIV factors
|
|
HIV Life Cycle
|
|
IL-9 Signaling Pathway
|
|
RNA Polymerase II Transcription
|
|
MicroRNAs in cardiomyocyte hypertrophy
|
|
DNA Damage Response
|
|
G1 to S cell cycle control
|
|
TGF beta Signaling Pathway
|
|
PPAR Alpha Pathway
|
|
MAP kinase activation in TLR cascade
|
|
RAF/MAP kinase cascade
|
|
Mitotic Prophase
|
|
Mitotic Prometaphase
|
|
BMI1
|
|
ATM Signaling Pathway
|
|
Retinoblastoma (RB) in Cancer
|
|
Spinal Cord Injury
|
|
Prostate Cancer
|
|
Regulation of Microtubule Cytoskeleton
|
|
Integrated Cancer pathway
|
|
Mitotic G2-G2/M phases
|
|
Mitotic G1-G1/S phases
|
|
Cell Cycle
|
|
APC/C-mediated degradation of cell cycle proteins
|
|
Cell Cycle Checkpoints
|
|
miRNA Regulation of DNA Damage Response
|
|
BDNF signaling pathway
|
|
Alzheimers Disease
|
|
Opioid Signalling
|
|
Semaphorin interactions
|
|
Factors involved in megakaryocyte development and platelet production
|
|
Nicotine Activity on Dopaminergic Neurons
|
|
ID signaling pathway
|
|
DNA Replication
|
|
M/G1 Transition
|
|
S Phase
|
|
Meiotic Recombination
|
|
Aryl Hydrocarbon Receptor
|
|
Integrated Pancreatic Cancer Pathway
|
|
Oncostatin M Signaling Pathway
|
|
Signaling Pathways in Glioblastoma
|
|
TSH signaling pathway
|
|
Integrated Breast Cancer Pathway
|
|
Synthesis of DNA
|
|
Regulation of DNA replication
|
